A Comprehensive Update of Lofexidine for the Management of Opioid Withdrawal Symptoms
Opiate addiction is increasing and plaguing the western world and specifically the U.S. It takes a large toll on both a personal and societal level and carries a high cost. Withdrawal is difficult, both related to withdrawal symptoms and renewed cravings. Lofexidine has been shown to be effective in reducing the former and could potentially aid in recovery and withdrawal.
Authors
- Celina G. Virgen (ORCID: https://orcid.org/0000-0002-6393-7525)
- Omar Viswanath (ORCID: https://orcid.org/0000-0002-6124-7037)
- Alan D. Kaye (ORCID: https://orcid.org/0000-0003-2464-0187)
- Robbie Zusman
- Jai Won Jung (ORCID: https://orcid.org/0009-0003-3175-8359)
- Amnon A. Berger (ORCID: https://orcid.org/0000-0001-7895-1357)
- Hisham Kassem (ORCID: https://orcid.org/0000-0002-3729-1900)
- Ivan Urits (ORCID: https://orcid.org/0000-0002-3652-6085)
- Jamal Hasoon (ORCID: https://orcid.org/0000-0001-8227-1864)
- Anjana Patel
- Mohammad Mousa
Institutions
- Georgetown University (US)
- Mount Sinai Medical Center (US)
Publication Details
- Journal
- Psychopharmacology Bulletin
- Published
- 2025-08-12
- DOI
- https://doi.org/10.64719/pb.4615
- Citations
- 23
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 11.27